These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 31138758)
1. Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1. Ding J; Sun D; Xie P Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138758 [No Abstract] [Full Text] [Related]
2. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR. Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300 [TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957 [TBL] [Abstract][Full Text] [Related]
4. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data. Wang Y; Jiang Y; Chen L J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676 [TBL] [Abstract][Full Text] [Related]
5. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7. Wang K; Jin J; Ma T; Zhai H Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Li GH; Ma ZH; Wang X Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709 [TBL] [Abstract][Full Text] [Related]
7. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis. Li M; Yu D; Li Z; Zhao C; Su C; Ning J Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645 [TBL] [Abstract][Full Text] [Related]
8. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway. Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182 [TBL] [Abstract][Full Text] [Related]
10. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma. Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway. You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324 [TBL] [Abstract][Full Text] [Related]
12. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3. Feng X; Luo Q; Wang H; Zhang H; Chen F J Cell Physiol; 2018 Sep; 233(9):6705-6713. PubMed ID: 29319163 [TBL] [Abstract][Full Text] [Related]
14. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1. Wang L; Liu H Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981 [TBL] [Abstract][Full Text] [Related]
15. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway. Zhu R; Mao Y; Xu X; Li Y; Zheng J Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942 [TBL] [Abstract][Full Text] [Related]
16. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression. Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589 [TBL] [Abstract][Full Text] [Related]
17. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
18. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways. Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression. Cai Z; Hao XY; Liu FX Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635 [TBL] [Abstract][Full Text] [Related]